CorMedix Inc. to Report First Quarter 2020 Financial Results and Provide a Corporate Update on May 11

NEXT STORY
Junshi Biosciences and Lilly to Co-develop Antibody Therapies for the Prevention and Treatment of COVID-19
PREV STORY
Bellerophon Therapeutics to Participate in COVID-19 Panel at Maxim Group’s Infectious Disease Virtual Conference
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Libtayo® (cemiplimab-rwlc) longer-term results in advanced cutaneous squamous cell carcinoma presented at ASCO 2020 show durable responses that deepen over time

author_avatar
NASDAQ Market News

Landos Biopharma Announces First Subject Dosed in a Phase 1 Study of LABP-104 for Systemic Lupus Erythematosus

author_avatar
NASDAQ Market News

Vaccitech Reports Third Quarter 2021 Financial Results and Recent Corporate Developments

author_avatar
NASDAQ Market News